Johnson & Johnson (JNJ) Income towards Parent Company (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Income towards Parent Company came in at $5.2 billion in Q1 2026, down 52.4% year-on-year from $11.0 billion in Q1 2025, and up 2.33% quarter-over-quarter from $5.1 billion in Q4 2025.

Johnson & Johnson (JNJ) Income towards Parent Company (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Income towards Parent Company across 17 years of filings, most recently posting $5.2 billion for Q1 2026.

  • Income towards Parent Company for Q1 2026 came in at $5.2 billion, down 52.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.0 billion (up 91.29% YoY), and the FY2023 annual result was $21.8 billion, up 1289.37% from the prior year.
  • Income towards Parent Company came in at $5.2 billion for Q1 2026 at Johnson & Johnson, up from $5.1 billion in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $21.7 billion in Q4 2023 to a low of -$232.0 million in Q3 2023.
  • The 4-year median for Income towards Parent Company is $578.0 million (2022), against an average of $4.3 billion.
  • Peak annual rise in Income towards Parent Company reached 14575.0% in 2023, while the deepest fall reached 142.03% in 2023.
  • Johnson & Johnson's Income towards Parent Company stood at $148.0 million in 2022, then plunged by 156.08% to -$83.0 million in 2023, then jumped by 6263.86% to $5.1 billion in 2025, then grew by 2.33% to $5.2 billion in 2026.
  • The last three Income towards Parent Company figures came in at $5.2 billion (Q1 2026), $5.1 billion (Q4 2025), and $5.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 31, 2023 -83.00 Mn
Oct 1, 2023 21.72 Bn
Jul 2, 2023 -232.00 Mn
Apr 2, 2023 423.00 Mn
Jan 1, 2023 293.00 Mn
Oct 2, 2022 148.00 Mn
Jul 3, 2022 552.00 Mn
Apr 3, 2022 578.00 Mn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn
Apr 4, 2021 6.20 Bn
Jan 3, 2021 1.74 Bn
Sep 27, 2020 3.55 Bn
Jun 28, 2020 3.63 Bn
Mar 29, 2020 5.80 Bn